Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 7, 2026
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
Hareesh B Nair, Ramadevi Subramani, Rajkumar Lakshmanaswamy
Biomedical Reports
|
October 22, 2019
Growth inhibitory efficacy and anti-aromatase activity of <i>Tabebuia avellanedae</i> in a model for post-menopausal Luminal A breast cancer
Nitin Telang, Hareesh B Nair, George Y C Wong
Pharmaceuticals (Basel, Switzerland)
|
December 28, 2021
Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
Oncology Letters
|
June 13, 2019
Growth inhibitory efficacy of <i>Cornus officinalis</i> in a cell culture model for triple-negative breast cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
Oncology Letters
|
December 18, 2024
Anti‑proliferative effects of <i>Drynaria fortunei</i> in a model for triple negative breast cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
International Journal of Molecular Sciences
|
May 28, 2025
Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target
Emily J Aller, Hareesh B Nair, Ratna K Vadlamudi, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 3, 2007
HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis
Rajeshwar Rao Tekmal, Hareesh B Nair, Rao P Perla, et al.
Steroids
|
April 12, 2011
Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy
Hareesh B Nair, Nameer B Kirma, Manonmani Ganapathy, et al.
Plos One
|
March 25, 2016
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
Hareesh B Nair, Bindu Santhamma, Naveen K Krishnegowda, et al.
Breast Cancer Research : BCR
|
October 14, 2009
BU-32: a novel proteasome inhibitor for breast cancer
Joseph K Agyin, Bindu Santhamma, Hareesh B Nair, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 7, 2026
Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies
Hareesh B Nair, Ramadevi Subramani, Rajkumar Lakshmanaswamy
Biomedical Reports
|
October 22, 2019
Growth inhibitory efficacy and anti-aromatase activity of <i>Tabebuia avellanedae</i> in a model for post-menopausal Luminal A breast cancer
Nitin Telang, Hareesh B Nair, George Y C Wong
Pharmaceuticals (Basel, Switzerland)
|
December 28, 2021
Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
Oncology Letters
|
June 13, 2019
Growth inhibitory efficacy of <i>Cornus officinalis</i> in a cell culture model for triple-negative breast cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
Oncology Letters
|
December 18, 2024
Anti‑proliferative effects of <i>Drynaria fortunei</i> in a model for triple negative breast cancer
Nitin T Telang, Hareesh B Nair, George Y C Wong
International Journal of Molecular Sciences
|
May 28, 2025
Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target
Emily J Aller, Hareesh B Nair, Ratna K Vadlamudi, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 3, 2007
HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis
Rajeshwar Rao Tekmal, Hareesh B Nair, Rao P Perla, et al.
Steroids
|
April 12, 2011
Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy
Hareesh B Nair, Nameer B Kirma, Manonmani Ganapathy, et al.
Plos One
|
March 25, 2016
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
Hareesh B Nair, Bindu Santhamma, Naveen K Krishnegowda, et al.
Breast Cancer Research : BCR
|
October 14, 2009
BU-32: a novel proteasome inhibitor for breast cancer
Joseph K Agyin, Bindu Santhamma, Hareesh B Nair, et al.
Page
of 5